MEDIA & COMMENTARY

Fraietta Laboratory in the Media (Featured Pieces)

Dr. Fraietta Receives National Clinical Research Achievement Award (Penn)

Penn Study Points to why T cell Therapy Fails in Some Patients (The Inquirer)

Healthy T cells have a Fighting Chance for cell Therapy (Penn) 

T cell Proliferation Linked to CAR T Responses (The Scientist)

A Single cell Spurs 5-year Remission for Penn Leukemia Patient (PhillyVoice)

CLL Patient Treated at Penn Goes into Remission Thanks to Single CAR T cell (Penn)

T cell Populations in CLL Patients Indicate Potential Success of CAR… (Drug Target Review)

BET Proteins and T cell Function (GTVLive Interview)

In First, Scientists Use CRISPR for Personalized Cancer Treatment (Scientific American)

CRISPR-edited Immune cells can Survive and Thrive after Infusion into Cancer Patients (Penn)

Existing Drug May Help Improve Responses to Cellular Therapies in Advanced Leukemias (Penn)

Tumour Tamed by Transfer of One T cell (Nature)

CLL Patient Goes into Remission Thanks to Single CAR T cell (Science Daily)

CAR-T and Other Cellular Therapies (CLL Society Webinar)

Can CRISPR Treat Cancer? (The Naked Scientists Interview)

CRISPR takes its First Steps in Editing Genes to Fight Cancer (The New York Times)

CAR T cells: Engineered to Attack Cancer (Talking Biotech Podcast Interview)

Novartis-backed Penn Study Proposes Boosting CAR-T Responses in CLL… (Fierce Biotech)

Addressing Exhausted T cells in CAR T Therapy (GTVLive Interview)

Penn Researchers Receive Grant to Develop CAR-T for Advanced Prostate Cancer (Healio)

Breakthrough Leukemia Treatment Backfires in a Rare Case (The New York Times)

Ibrutinib Supercharges CAR T cells (Nature Reviews Clinical Oncology)

Translational Research: Cancer Killers (Nature)

Can Culturing CAR T cells With Ibrutinib… (Cancer Therapy Advisor Interview)

Armored CAR T Cells Break Through Immune Suppression in Solid Tumors (The Scientist)

The Future of CRISPR in Cancer Research & Treatment (Oncology Times Interview)

Investigating Molecular Pathways of CAR T cell Resistance (GTVLive Interview)